Wagner Wealth Management (South Carolina)’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
Other funds holding MRNA
FP
TP
Wagner Wealth Management (South Carolina)'s MRNA Position: Q4 2022 in Review
Wagner Wealth Management (South Carolina) sold out of Moderna (MRNA) in Q4 2022, closing a stake of 98 shares — an estimated $12K sold.
Wagner Wealth Management (South Carolina) first reported a position in MRNA in Q1 2021 and held it in 6 quarters. The position peaked at $38K in Q3 2021. 1,072 funds tracked by Wall St. Rank hold MRNA as of Q4 2022.
- Wagner Wealth Management (South Carolina) reported no remaining Moderna position as of Q4 2022 after selling out during the quarter.
- Wagner Wealth Management (South Carolina) sold 98 Moderna shares in Q4 2022, an estimated $12K.
- Wagner Wealth Management (South Carolina) first reported a position in Moderna in Q1 2021 and held it in 6 quarters.
- Wagner Wealth Management (South Carolina)'s Moderna position peaked at $38K in Q3 2021.
- 1,072 funds tracked by Wall St. Rank held Moderna as of Q4 2022.
Based on Wagner Wealth Management (South Carolina)'s 13F filing for Q4 2022, filed 14 Feb 2023.